Fondazione G.b. Bietti, Irccs
Clinical trials sponsored by Fondazione G.b. Bietti, Irccs, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Vision training may lift mood in macular degeneration patients Results expected Dec 2026 (estimated)
- Scientists hunt for protein clues in common eye diseases Results expected Jan 2027 (estimated)
-
Could a light beam slow vision loss? new trial tests laser therapy for AMD
Disease control Not yet recruitingThis study tests a non-invasive laser treatment called photobiomodulation for people with early age-related macular degeneration (AMD) who have a specific type of deposit in the eye called reticular pseudodrusen. The treatment uses low-energy light to stimulate cells and reduce i…
Sponsor: Fondazione G.B. Bietti, IRCCS • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
AI eye exam could spot glaucoma in seconds
Diagnosis Not yet recruitingThis study tests an artificial intelligence (AI) system called GlaukomAI that analyzes standard eye photos to detect glaucoma, a leading cause of blindness. Researchers will enroll 1,200 participants to see how accurately the AI identifies glaucoma compared to expert doctors. If …
Sponsor: Fondazione G.B. Bietti, IRCCS • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
New eye imaging study aims to map retinal disease progression
Knowledge-focused Not yet recruitingThis observational study will use advanced imaging techniques to measure changes in the retina and choroid (the layer beneath the retina) in people with eye diseases and healthy volunteers. Over 5 years, researchers will track thickness and blood vessel density to better understa…
Sponsor: Fondazione G.B. Bietti, IRCCS • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC